Related Experiment Videos
Pathological haemostasis and "prothrombotic state" in Behçet's disease
Sedat Kiraz1, Ihsan Ertenli, M Akif Oztürk
1Department of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
Thrombosis Research
|April 18, 2002
Summary
Behçet's disease (BD) involves widespread vasculitis and a prothrombotic state. This review examines genetic defects, coagulation, fibrinolysis, and endothelial dysfunction in BD thrombosis to guide new treatments.
Area of Science:
- Rheumatology and Hematology
- Vascular Biology and Thrombosis
Background:
- Behçet's disease (BD) is characterized by occlusive vasculitis affecting all vessel types.
- BD exhibits a unique vasculopathy with a significant hypercoagulable/prothrombotic state.
- Evidence suggests universal activation of the hemostatic system in BD patients.
Purpose of the Study:
- To review current literature and expert experience on the prothrombotic state in Behçet's disease.
- To explore genetic thrombotic defects, hemostatic markers, coagulation, fibrinolysis, and endothelial dysfunction in BD.
- To discuss challenges, future prospects, and novel antithrombotic strategies for BD-associated thrombosis.
Main Methods:
- Comprehensive review of existing literature on BD pathogenesis and thrombosis.
- Analysis of data concerning genetic factors, coagulation markers, and endothelial function.
- Synthesis of clinical aspects, genetic basis, and therapeutic strategies.
Main Results:
- Elevated procoagulant markers indicate excessive thrombin formation in BD.
- Impaired fibrinolysis and endothelial injury/dysfunction contribute to the prothrombotic state.
- Genetic defects in coagulation are increasingly recognized in BD.
Conclusions:
- Understanding the complex pathogenesis of the hypercoagulable state in BD is crucial.
- Further research into genetic thrombotic defects and endothelial dysfunction is warranted.
- Novel antithrombotic and antiplatelet therapies hold promise for improved patient outcomes.